NBS

Combining newborn metabolic and DNA analysis for second- tier testing of methylmalonic acidemia

**Purpose:** Improved second-tier tools are needed to reduce false- positive outcomes in newborn screening (NBS) for inborn metabolic disorders on the Recommended Universal Screening Panel (RUSP). **Methods:** We designed an assay for multiplex …

Elevated methylmalonic acidemia (MMA) screening markers in Hispanic and preterm newborns

Analysis of California newborn screening (NBS) data revealed a high prevalence of Hispanic infants testing positive for methylmalonic acidemia (MMA), a trend seen for both true- and false-positive cases. Here we show that Hispanic infants have …

Next-generation molecular testing of newborn dried blood spots for cystic fibrosis

Newborn screening for cystic fibrosis enables early detection and management of this debilitating genetic disease. Implementing comprehensive CFTR analysis using Sanger sequencing as a component of confirmatory testing of all screen-positive newborns …